Last reviewed · How we verify

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil

NCT04994860 PHASE1 COMPLETED

The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg on the pharmacokinetics (PK) of sildenafil. * To assess the effect of sildenafil on the PK of BIA 5-1058.

Details

Lead sponsorBial - Portela C S.A.
PhasePHASE1
StatusCOMPLETED
Enrolment20
Start dateThu Mar 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionThu Jun 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Germany